ClinicalTrials.gg
Sign In

Anaphylaxis clinical trials

The registry lists 100 studies for Anaphylaxis across more than 10 countries. 20 are recruiting or about to start. 51 of them are mainly about Anaphylaxis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30.

Get an email when these change. Save the Anaphylaxis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
57
Recruiting
16
Status unknown
12
Terminated
4
Active, not recruiting
4
Withdrawn
2

Phase

Phase 1
15
Phase 2
11
Phase 4
7
Phase 3
4

Where

United States
25
France
17
Canada
9
United Kingdom
7
China
4
Australia
4

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (5) · Assistance Publique - Hôpitaux de Paris (5) · Nasus Pharma (4) · University Hospital, Montpellier (3) · Central Hospital, Nancy, France (3) · Charite University, Berlin, Germany (2) · Imperial College London (2) · Dr. George Luciuk (2)

What is being tested here

Drugs under test in Anaphylaxis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Epinephrine2010
Dexamethasone101
cow's milk002
Peanut002
Omalizumab002
Prebiotics001
KP-001001
Chlorpheniramine001
Ranitidine001
Acetaminophen001

Drug classes tested here Bronchodilators 2 open

Coming up

2phase 3 studies under way
7studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7, phase 3 first

Who these studies take

Of the 16 Anaphylaxis studies recruiting now, 10 (63%) set no upper age limit and 5 (31%) stop at 75 or younger. 10 (63%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (25%) take healthy volunteers.

Recruiting studies that take each age, of 16
AgeWomenMen
108 (50%)8 (50%)
1814 (88%)14 (88%)
3013 (81%)13 (81%)
4013 (81%)13 (81%)
5013 (81%)13 (81%)
6513 (81%)13 (81%)
7511 (69%)11 (69%)
8511 (69%)11 (69%)

Across all 100 studies, recruiting or not: 52% stop at 75 or younger and 44% at 65; 54% take children; 0% are for women only and 1% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Anaphylaxis studies take

Of 13 interventional studies with no phase under Anaphylaxis, half reached primary completion within 12 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase12 mo6–37 · 13 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 100. Browse all 100 → or search them.